Project: Advanced in vivo imaging service for preclinical models to improve therapies in Autoimmune Diseases

The consortium offers services of advanced in vivo imaging analysis in preclinical animal models of autoimmune conditions, including specialised models of orphan diseases, for the pharmaceutical industry. The inclusion of in vivo imaging of joint and CNS pathologies in whole animals, often requested by customers for drug evaluation, provides a more detailed and extensive evaluation of new drugs and improves the selection of the best drugs for further development and clinical trials.

Acronym	IMAID (Reference Number: 9215)
Duration	01/01/2015 - 01/01/2017
Project Topic	Biological Sciences / Technologies
Network	Eurostars 2
Call	Eurostars Cut-Off 2

Project partner

Number	Name	Role	Country
19932	Redoxis AB	Coordinator	Sweden
19933	Image Analysis	Partner	United Kingdom